STIM Stock Overview
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Neuronetics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.83 |
| 52 Week High | US$6.95 |
| 52 Week Low | US$1.98 |
| Beta | 2.12 |
| 1 Month Change | -7.61% |
| 3 Month Change | 78.29% |
| 1 Year Change | 68.99% |
| 3 Year Change | 60.61% |
| 5 Year Change | n/a |
| Change since IPO | -79.01% |
Recent News & Updates
Recent updates
Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?
Sep 06
Is Neuronetics (NASDAQ:STIM) A Risky Investment?
Jun 08Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?
Jan 19Is Neuronetics (NASDAQ:STIM) Using Debt In A Risky Way?
Oct 14Is Neuronetics (NASDAQ:STIM) A Risky Investment?
Jul 05Can You Imagine How Elated Neuronetics' (NASDAQ:STIM) Shareholders Feel About Its 980% Share Price Gain?
Mar 18This Insider Has Just Sold Shares In Neuronetics, Inc. (NASDAQ:STIM)
Feb 11
Should You Take Comfort From Insider Transactions At Neuronetics, Inc. (NASDAQ:STIM)?
Jan 26What Is The Ownership Structure Like For Neuronetics, Inc. (NASDAQ:STIM)?
Dec 28Health Check: How Prudently Does Neuronetics (NASDAQ:STIM) Use Debt?
Nov 30Shareholder Returns
| STIM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.3% | -0.1% | 2.3% |
| 1Y | 69.0% | -9.6% | -9.7% |
Return vs Industry: STIM exceeded the US Medical Equipment industry which returned -8.2% over the past year.
Return vs Market: STIM exceeded the US Market which returned -8.5% over the past year.
Price Volatility
| STIM volatility | |
|---|---|
| STIM Average Weekly Movement | 8.9% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: STIM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: STIM's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 198 | Keith Sullivan | https://www.neurostar.com |
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
Neuronetics, Inc. Fundamentals Summary
| STIM fundamental statistics | |
|---|---|
| Market Cap | US$158.70m |
| Earnings (TTM) | -US$36.50m |
| Revenue (TTM) | US$62.03m |
2.6x
P/S Ratio-4.3x
P/E RatioIs STIM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STIM income statement (TTM) | |
|---|---|
| Revenue | US$62.03m |
| Cost of Revenue | US$14.63m |
| Gross Profit | US$47.40m |
| Other Expenses | US$83.90m |
| Earnings | -US$36.50m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.34 |
| Gross Margin | 76.41% |
| Net Profit Margin | -58.85% |
| Debt/Equity Ratio | 56.8% |
How did STIM perform over the long term?
See historical performance and comparison